Referral to Nephrologists Mitigates the Progression of Kidney Dysfunction in Patients with Type 2 Diabetes: A Causal Inference Study

Background: Chronic kidney disease is a major complication of type 2 diabetes, necessitating effective management to mitigate kidney progression. This study evaluates the effect of referrals from endocrinologists to nephrologists on kidney function in diabetic patients through causal inference analysis. Methods: This study included patients with type 2 diabetes who initially visited the diabetes clinic between July 2004 and November 2023. Patients were either referred to a nephrology clinic or continued under the care of endocrinologists. The slope of eGFR per year was calculated based on the annual median difference in yearly eGFRs, and cases were censored when the values dropped below 10ml/min/1.73m2. We applied a difference-in-differences model to this time-series dataset with an inverse propensity weighting estimator to evaluate the effect of referral to nephrologists. Results: Among 30,160 patients who visited the diabetes clinic, 3,885 patients (13%) were referred to nephrologists (referral group), while others continued under the care of endocrinologists alone (no referral group). The referral group, compared to the no referral group, had low baseline eGFR (73 [IQR, 59–87] vs 88 [76–98] ml/min/1.73m2) and high uACR (38 [12–199] vs 14 [8–39] mg/g). The averaged treatment effect of referral to nephrologists displayed an improvement in the eGFR slope, with an increase of 5.8 (95% CI, 4.8–6.8) ml/min/1.73m2/year. The referral group exhibited higher usage of antihypertensive agents and hypoglycemic agents other than metformin (e.g., DPP-4i and SGLT2i) than the no referral group. Kidney biopsies were more frequently performed in the referral group than in the no referral group (3.8% vs 0.05%), and 50% of patients who received biopsies were diagnosed with other diseases, with or without diabetic nephropathy. Conclusion: Referral to nephrologists reduces the progression of kidney dysfunction in patients with type 2 diabetes, supporting the need for appropriate referral to nephrologists in type 2 diabetic patients.The event study plot of the nephrology referral on average treatment effect.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024t5cwxdq8
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Referral to Nephrologists Mitigates the Progression of Kidney Dysfunction in Patients with Type 2 Diabetes: A Causal Inference Study

Donghwan Yun, Seung Seok Han, Yon Su Kim, Dong Ki Kim
Journal of the American Society of Nephrology
Blood Pressure and Hypertension Studies
article

Referral to Nephrologists Mitigates the Progression of Kidney Dysfunction in Patients with Type 2 Diabetes: A Causal Inference Study

Donghwan Yun, Seung Seok Han, Yon Su Kim, Dong Ki Kim
article en

Abstract

Background: Chronic kidney disease is a major complication of type 2 diabetes, necessitating effective management to mitigate kidney progression. This study evaluates the effect of referrals from endocrinologists to nephrologists on kidney function in diabetic patients through causal inference analysis. Methods: This study included patients with type 2 diabetes who initially visited the diabetes clinic between July 2004 and November 2023. Patients were either referred to a nephrology clinic or continued under the care of endocrinologists. The slope of eGFR per year was calculated based on the annual median difference in yearly eGFRs, and cases were censored when the values dropped below 10ml/min/1.73m2. We applied a difference-in-differences model to this time-series dataset with an inverse propensity weighting estimator to evaluate the effect of referral to nephrologists. Results: Among 30,160 patients who visited the diabetes clinic, 3,885 patients (13%) were referred to nephrologists (referral group), while others continued under the care of endocrinologists alone (no referral group). The referral group, compared to the no referral group, had low baseline eGFR (73 [IQR, 59–87] vs 88 [76–98] ml/min/1.73m2) and high uACR (38 [12–199] vs 14 [8–39] mg/g). The averaged treatment effect of referral to nephrologists displayed an improvement in the eGFR slope, with an increase of 5.8 (95% CI, 4.8–6.8) ml/min/1.73m2/year. The referral group exhibited higher usage of antihypertensive agents and hypoglycemic agents other than metformin (e.g., DPP-4i and SGLT2i) than the no referral group. Kidney biopsies were more frequently performed in the referral group than in the no referral group (3.8% vs 0.05%), and 50% of patients who received biopsies were diagnosed with other diseases, with or without diabetic nephropathy. Conclusion: Referral to nephrologists reduces the progression of kidney dysfunction in patients with type 2 diabetes, supporting the need for appropriate referral to nephrologists in type 2 diabetic patients.The event study plot of the nephrology referral on average treatment effect.

Journal of the American Society of NephrologyVol. 35(10S)
New Generation University College (ET)
Openalex Percentile: Top 65%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.